Physician profile
Rajeev Pillai
NPI 1093970071
$3,809.87
in general payments reported to CMS, 2019-2025
26 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $208 · 2021: $262 · 2022: $908 · 2023: $389 · 2024: $328 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,421.34 | 2019 | |
| Angiodynamics, INC. | $691.17 | 2022-2023 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $356.29 | 2019-2025 | Lifevest |
| Abiomed | $239.96 | 2020-2021 | |
| Inari Medical, INC. | $198.68 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $130.01 | 2021-2023 | |
| Cardiovascular Systems INC. | $115.62 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $100.09 | 2019-2022 | |
| Biotronik INC. | $99.20 | 2022-2023 | Edora 8 Dr-T |
| Stryker Corporation | $84.53 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, N/A |
| Novartis Pharmaceuticals Corporation | $50.04 | 2022-2024 | |
| Abbott Laboratories | $41.68 | 2022-2023 | Cardiomems |
| Kestra Medical Technology Services, INC. | $35.68 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $31.32 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.11 | 2024 | Jardiance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $27.31 | 2025 | |
| Cordis US Corp. | $23.54 | 2023 | Rain Sheath Transradial |
| Scpharmaceuticals INC. | $21.60 | 2023 | |
| Penumbra, INC. | $20.13 | 2025 | Indigo System |
| Cook Medical LLC | $18.55 | 2020 | |
| Chiesi USA, INC. | $16.36 | 2021 | |
| Medtronic, INC. | $16.12 | 2024 | Venaseal |
| Novo Nordisk INC | $13.51 | 2020 | |
| Amgen INC. | $12.94 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.66 | 2020 | |
| Z-Medica, LLC | $4.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Pillai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.